Position in HIMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,904,396
+$3,904,396 QoQ
Shares Held
112,616
-55.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#112
of 506 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $70,030,747 across 11 Drug Manufacturers - Specialty & Generic names. HIMS ranks #4 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
925,408 | $31,352,823 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
979,269 | $24,099,810 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
838,088 | $8,238,405 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
This page
|
112,616 | $3,904,396 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
299,232 | $1,475,213 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
2,809 | $473,428 | |
| 7 | VTRS |
Viatris Inc
|
29,678 | $471,286 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
402 | $6,958 |
All Filings in HIMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,904,396 | 112,616 | Shares | Sole | 2026-08-13 | |
| 2020-12-31 OAC | — | 250,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 OAC | — | 149,999 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 OAC | — | 349,999 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 OAC | — | 150,000 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||